Exact Mass: 490.2256

alpha-Crocetin glucosyl ester

C26H34O9 (490.2203)

Beta-D-glucosyl crocetin is a dicarboxylic acid monoester resulting from the formal condensation of one of the carboxylic acid groups of crocetin with the anomeric hydroxy group of beta-D-glucopyranose. It is a dicarboxylic acid monoester and a beta-D-glucoside. It is functionally related to a crocetin and a beta-D-glucose. It is a conjugate acid of a beta-D-glucosyl crocetin(1-). beta-D-glucosyl crocetin is a natural product found in Gardenia jasminoides and Crocus sativus with data available. Alpha-Crocetin glucosyl ester is found in herbs and spices. Alpha-Crocetin glucosyl ester is isolated from saffron. Isolated from saffron [DFC]. alpha-Crocetin glucosyl ester is found in saffron and herbs and spices.

Glimepiride

C24H34N4O5S (490.225)

Glimepiride is only found in individuals that have used or taken this drug. It is the first III generation sulphonyl urea it is a very potent sulphonyl urea with long duration of action.The mechanism of action of glimepiride in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin. Glimepiride likely binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-sensitive calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D007004 - Hypoglycemic Agents

deoxylimonoic acid D-ring-lactone

C26H34O9 (490.2203)

Deacetylnomilinic acid

C26H34O9 (490.2203)

Deacetylnomilinic acid is found in citrus. Deacetylnomilinic acid is a constituent of the extract of grapefruit seeds Constituent of the extract of grapefruit seeds. Deacetylnomilinic acid is found in citrus.

Austalide F

C26H34O9 (490.2203)

Austalide F is a mycotoxin of Aspergillus ustu Mycotoxin of Aspergillus ustus

4-Oxo-9-cis-retinoyl-beta-glucuronide

C26H34O9 (490.2203)

This compound belongs to the family of Diterpene Glycosides. These are diterpenes in which an isoprene unit is glycosylated.

Estradiol acetate glucuronide

C26H34O9 (490.2203)

Estradiol acetate glucuronide belongs to the class of organic compounds known as steroid glucuronide conjugates. These are sterol lipids containing a glucuronide moiety linked to the steroid skeleton.

4-Ketoretinoic acid glucuronide

C26H34O9 (490.2203)

4-Ketoretinoic acid glucuronide belongs to the class of organic compounds known as diterpene glycosides. These are diterpenoids in which an isoprene unit is glycosylated.

Niludipine

C25H34N2O8 (490.2315)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

Bis(2-propoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate

C25H34N2O8 (490.2315)

PA(2:0/18:2(10E,12Z)+=O(9))

C23H39O9P (490.2332)

PA(2:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(10E,12Z)+=O(9)/2:0)

C23H39O9P (490.2332)

PA(18:2(10E,12Z)+=O(9)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(10E,12Z)+=O(9)/2:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/18:2(9Z,11E)+=O(13))

C23H39O9P (490.2332)

PA(2:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(9Z,11E)+=O(13)/2:0)

C23H39O9P (490.2332)

PA(18:2(9Z,11E)+=O(13)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(9Z,11E)+=O(13)/2:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/18:3(10,12,15)-OH(9))

C23H39O9P (490.2332)

PA(2:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(10,12,15)-OH(9)/2:0)

C23H39O9P (490.2332)

PA(18:3(10,12,15)-OH(9)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(10,12,15)-OH(9)/2:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/18:3(9,11,15)-OH(13))

C23H39O9P (490.2332)

PA(2:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(9,11,15)-OH(13)/2:0)

C23H39O9P (490.2332)

PA(18:3(9,11,15)-OH(13)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(9,11,15)-OH(13)/2:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Parvifoline G

C26H34O9 (490.2203)

Reissantin E

C26H34O9 (490.2203)

Sudachinoid A

C26H34O9 (490.2203)

Murrastifoline D

C32H30N2O3 (490.2256)

Terrequinone A

C32H30N2O3 (490.2256)

A bisindole alkaloid that is quinone bearing a hydroxy substituent at position 2, a 3,3-dimethylallyl group at position 5 and two indol-3-yl groups at positions 3 and 6, one of which is carrying a 1,1-dimethylallyl group at position 2.

Glabcensin Q

C26H34O9 (490.2203)

[3R-(3alpha,4beta,5alpha,5aalpha,6alpha,9beta,9aalpha,10R*)]-Octahydro-2,2,5a,9-tetramethyl-, 5,10-diacetate 6-benzoate H-3,9a-methano-1-benzoxepin-4,5,6,9,10-pentol

C26H34O9 (490.2203)

Lungshengenin G

C26H34O9 (490.2203)

Justin C

C26H34O9 (490.2203)

Justin C is a natural product found in Justicia procumbens with data available.

Teucrolin C

C26H34O9 (490.2203)

Adenanthin

C26H34O9 (490.2203)

Adenanthin is a natural product found in Isodon tenuifolius, Isodon adenanthus, and other organisms with data available.

Deacetylnomilinic acid

C26H34O9 (490.2203)

(1R,2R,4S,7S,8R,9R,10S,11R,12S,13S,14R,17R,18R,19R)-8-(acetyloxy)-10,19-dihydroxy-1,9,18-trimethyl-15-oxo-16,20-dioxahexacyclo[15.3.2.0²,¹³.0⁴,¹².0⁷,¹¹.0¹⁴,¹⁹]docos-5-ene-5-carboxylic acid

C26H34O9 (490.2203)

NSC135079

C26H34O9 (490.2203)

2-Ac-(2beta,3beta,5beta,11alpha,14beta)-2,3,5,11,14-Pentahydroxy-12-oxobufa-20,22-dienolide

C26H34O9 (490.2203)

caesalpinin MM

C26H34O9 (490.2203)

11-O-??-D-Xylopyranosylmyricanol

C26H34O9 (490.2203)

3-Ac-(2beta,3beta,5beta,11alpha,14beta)-2,3,5,11,14-Pentahydroxy-12-oxobufa-20,22-dienolide

C26H34O9 (490.2203)

Shikokianidin

C26H34O9 (490.2203)

Teubutilin B

C26H34O9 (490.2203)

Crassolid

C26H34O9 (490.2203)

C26H34O9

C26H34O9 (490.2203)

[(1R,2R,4R,6S,8S,9S,10S,11S,13S)-2,8-diacetyloxy-6-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxo-11-tetracyclo[11.2.1.0^{1,10.0^{4,9]hexadecanyl] acetate

C26H34O9 (490.2203)

Acetylexidonin

C26H34O9 (490.2203)

Acetylexidonin is a natural product found in Isodon rubescens with data available.

bryophyllin B

C26H34O9 (490.2203)

(1S,4S,5S,6R,7R,8S,9R,10S)-1,6-diacetoxy-9-benzoyloxy-4,8-dihydroxy-dihydro-beta-agarofuran

C26H34O9 (490.2203)

austalide O

C26H34O9 (490.2203)

michaolide M

C26H34O9 (490.2203)

(- )-(3S,7S)-ericanone 3-O-beta-D-xylopyranoside|ericanone 3-O-beta-D-xylopyranoside

C26H34O9 (490.2203)

Massonianoside B

C26H34O9 (490.2203)

klymollin L

C24H39ClO8 (490.2333)

Rabdoepigibberellolide

C26H34O9 (490.2203)

shikokianal acetate

C26H34O9 (490.2203)

briareolide H

C26H34O9 (490.2203)

(1R*,2R*,3R*,5Z,7S*,8(17)E,10R*,11R*,12S*,14S*)-2,3,14-triacetoxy-11,12-epoxybriara-5,8(17)-dien-18-one|(1R*,2R*,3R*,5Z,7S*,8(17)Z,10R*,11R*,12S*,14S*)-2,3,14-triacetoxy-11,12-epoxybriara-5,8(17)-dien-18-one

C26H34O9 (490.2203)

leucophyllin A

C26H34O9 (490.2203)

methyl rel-(1R,4aR,8R)-7-(1-(methoxycarbonyl)vinyl)-5,8-diacetoxy-1,2,3,4a,5,6,7,8,9,10,10a-dodecahydro-1,4a-dimethyl-2-oxophenanthrene-1-carboxylate

C26H34O9 (490.2203)

(2S,4S,5S,7S,8E,10S,11R)-7-hydroxy-4,14,15,15-tetramethyl-3,13-dioxotricyclo[9.3.1.1(4,8)]hexadeca-1(14),8-diene-2,5,10-triyl triacetate|2alpha,7beta,10alpha-triacetoxy-5alpha-hydroxy-2(3->20)-abeo-taxa-4(20),11-dien-9,13-dione

C26H34O9 (490.2203)

PHORBOL-12,13,20-TRIACETATE

C26H34O9 (490.2203)

juncenolide K|rel-(2R,3aS,4Z,8S,8aS,9S,12aS,13S)-8,9,13-tris(acetyloxy)-3a,6,7,8,8a,9,10,11,12a,13-decahydro-1,5,8a-trimethylspiro[benzo[4,5]cyclodeca[1,2-b]furan-12(2H),2-oxiran]-2-one

C26H34O9 (490.2203)

3beta,15beta,19-triacetoxy-6-oxo-6,7-seco-ent-kaur-16-en-7,20-olide|maoesin F

C26H34O9 (490.2203)

SCHEMBL8236960

C26H34O9 (490.2203)

Thr Leu Asp Glu

C20H34N4O10 (490.2275)

glimepiride

C24H34N4O5S (490.225)

A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 2355 CONFIDENCE standard compound; INTERNAL_ID 8512

C26H34O9_12H-3,5a-Epoxy-5H-furo[3,4-i]oxepino[4,3-a]xanthen-12-one, 1,2,3,6,7,7a,10,14,14a,14b-decahydro-6-hydroxy-5-(hydroxymethyl)-3,13-dimethoxy-5,7a,9,14b-tetramethyl

C26H34O9 (490.2203)

C26H34O9

C26H34O9 (490.2203)

C26H34O9_(1R,2R,4S,7S,8R,9R,10S,11R,12S,13S,14R,17R,18R,19R)-8-Acetoxy-10,19-dihydroxy-1,9,18-trimethyl-15-oxo-16,20-dioxahexacyclo[15.3.2.0~2,13~.0~4,12~.0~7,11~.0~14,19~]docos-5-ene-5-carboxylic acid

C26H34O9 (490.2203)

C26H34O9_12H-3,5a-Epoxy-5H-furo[3,4-i]oxepino[4,3-a]xanthen-12-one, 1,2,3,6,7,7a,10,14,14a,14b-decahydro-2,6-dihydroxy-3,13-dimethoxy-5,5,7a,9,14b-pentamethyl

C26H34O9 (490.2203)

Mascaroside II

C26H34O9 (490.2203)

Ala Met Asn Arg

C18H34N8O6S (490.2322)

Ala Met Arg Asn

C18H34N8O6S (490.2322)

Ala Asn Met Arg

C18H34N8O6S (490.2322)

Ala Asn Arg Met

C18H34N8O6S (490.2322)

Ala Arg Met Asn

C18H34N8O6S (490.2322)

Ala Arg Asn Met

C18H34N8O6S (490.2322)

Cys Ile Gln Gln

C19H34N6O7S (490.221)

Cys Leu Gln Gln

C19H34N6O7S (490.221)

Cys Asn Arg Val

C18H34N8O6S (490.2322)

Cys Asn Val Arg

C18H34N8O6S (490.2322)

Cys Gln Ile Gln

C19H34N6O7S (490.221)

Cys Gln Leu Gln

C19H34N6O7S (490.221)

Cys Gln Gln Ile

C19H34N6O7S (490.221)

Cys Gln Gln Leu

C19H34N6O7S (490.221)

Cys Arg Asn Val

C18H34N8O6S (490.2322)

Cys Arg Val Asn

C18H34N8O6S (490.2322)

Cys Val Asn Arg

C18H34N8O6S (490.2322)

Cys Val Arg Asn

C18H34N8O6S (490.2322)

Glu Glu Ile Thr

C20H34N4O10 (490.2275)

Glu Glu Leu Thr

C20H34N4O10 (490.2275)

Glu Glu Thr Ile

C20H34N4O10 (490.2275)

Glu Glu Thr Leu

C20H34N4O10 (490.2275)

Glu Ile Glu Thr

C20H34N4O10 (490.2275)

Glu Ile Thr Glu

C20H34N4O10 (490.2275)

Glu Leu Glu Thr

C20H34N4O10 (490.2275)

Glu Leu Thr Glu

C20H34N4O10 (490.2275)

Glu Thr Glu Ile

C20H34N4O10 (490.2275)

Glu Thr Glu Leu

C20H34N4O10 (490.2275)

Glu Thr Ile Glu

C20H34N4O10 (490.2275)

Glu Thr Leu Glu

C20H34N4O10 (490.2275)

Phe Met Pro Pro

C24H34N4O5S (490.225)

Phe Pro Met Pro

C24H34N4O5S (490.225)

Phe Pro Pro Met

C24H34N4O5S (490.225)

Gly Met Gln Arg

C18H34N8O6S (490.2322)

Gly Met Arg Gln

C18H34N8O6S (490.2322)

Gly Gln Met Arg

C18H34N8O6S (490.2322)

Gly Gln Arg Met

C18H34N8O6S (490.2322)

Gly Arg Met Gln

C18H34N8O6S (490.2322)

Gly Arg Gln Met

C18H34N8O6S (490.2322)

His His Pro Thr

C21H30N8O6 (490.2288)

His His Thr Pro

C21H30N8O6 (490.2288)

His Pro His Thr

C21H30N8O6 (490.2288)

His Pro Thr His

C21H30N8O6 (490.2288)

His Thr His Pro

C21H30N8O6 (490.2288)

His Thr Pro His

C21H30N8O6 (490.2288)

Ile Cys Gln Gln

C19H34N6O7S (490.221)

Ile Glu Glu Thr

C20H34N4O10 (490.2275)

Ile Glu Thr Glu

C20H34N4O10 (490.2275)

Ile Met Met Pro

C21H38N4O5S2 (490.2283)

Ile Met Asn Asn

C19H34N6O7S (490.221)

Ile Met Pro Met

C21H38N4O5S2 (490.2283)

Ile Asn Met Asn

C19H34N6O7S (490.221)

Ile Asn Asn Met

C19H34N6O7S (490.221)

Ile Pro Met Met

C21H38N4O5S2 (490.2283)

Ile Gln Cys Gln

C19H34N6O7S (490.221)

Ile Gln Gln Cys

C19H34N6O7S (490.221)

Ile Thr Glu Glu

C20H34N4O10 (490.2275)

Leu Cys Gln Gln

C19H34N6O7S (490.221)

Leu Glu Glu Thr

C20H34N4O10 (490.2275)

Leu Glu Thr Glu

C20H34N4O10 (490.2275)

Leu Met Met Pro

C21H38N4O5S2 (490.2283)

Leu Met Asn Asn

C19H34N6O7S (490.221)

Leu Met Pro Met

C21H38N4O5S2 (490.2283)

Leu Asn Met Asn

C19H34N6O7S (490.221)

Leu Asn Asn Met

C19H34N6O7S (490.221)

Leu Pro Met Met

C21H38N4O5S2 (490.2283)

Leu Gln Cys Gln

C19H34N6O7S (490.221)

Leu Gln Gln Cys

C19H34N6O7S (490.221)

Leu Thr Glu Glu

C20H34N4O10 (490.2275)

Met Ala Asn Arg

C18H34N8O6S (490.2322)

Met Ala Arg Asn

C18H34N8O6S (490.2322)

Met Phe Pro Pro

C24H34N4O5S (490.225)

Met Gly Gln Arg

C18H34N8O6S (490.2322)

Met Gly Arg Gln

C18H34N8O6S (490.2322)

Met Ile Met Pro

C21H38N4O5S2 (490.2283)

Met Ile Asn Asn

C19H34N6O7S (490.221)

Met Ile Pro Met

C21H38N4O5S2 (490.2283)

Met Leu Met Pro

C21H38N4O5S2 (490.2283)

Met Leu Asn Asn

C19H34N6O7S (490.221)

Met Leu Pro Met

C21H38N4O5S2 (490.2283)

Met Met Ile Pro

C21H38N4O5S2 (490.2283)

Met Met Leu Pro

C21H38N4O5S2 (490.2283)

Met Met Pro Ile

C21H38N4O5S2 (490.2283)

Met Met Pro Leu

C21H38N4O5S2 (490.2283)

Met Asn Ala Arg

C18H34N8O6S (490.2322)

Met Asn Ile Asn

C19H34N6O7S (490.221)

Met Asn Leu Asn

C19H34N6O7S (490.221)

Met Asn Asn Ile

C19H34N6O7S (490.221)

Met Asn Asn Leu

C19H34N6O7S (490.221)

Met Asn Gln Val

C19H34N6O7S (490.221)

Met Asn Arg Ala

C18H34N8O6S (490.2322)

Met Asn Val Gln

C19H34N6O7S (490.221)

Met Pro Phe Pro

C24H34N4O5S (490.225)

Met Pro Ile Met

C21H38N4O5S2 (490.2283)

Met Pro Leu Met

C21H38N4O5S2 (490.2283)

Met Pro Met Ile

C21H38N4O5S2 (490.2283)

Met Pro Met Leu

C21H38N4O5S2 (490.2283)

Met Pro Pro Phe

C24H34N4O5S (490.225)

Met Gln Gly Arg

C18H34N8O6S (490.2322)

Met Gln Asn Val

C19H34N6O7S (490.221)

Met Gln Arg Gly

C18H34N8O6S (490.2322)

Met Gln Val Asn

C19H34N6O7S (490.221)

Met Arg Ala Asn

C18H34N8O6S (490.2322)

Met Arg Gly Gln

C18H34N8O6S (490.2322)

Met Arg Asn Ala

C18H34N8O6S (490.2322)

Met Arg Gln Gly

C18H34N8O6S (490.2322)

Met Val Asn Gln

C19H34N6O7S (490.221)

Met Val Gln Asn

C19H34N6O7S (490.221)

Asn Ala Met Arg

C18H34N8O6S (490.2322)

Asn Ala Arg Met

C18H34N8O6S (490.2322)

Asn Cys Arg Val

C18H34N8O6S (490.2322)

Asn Cys Val Arg

C18H34N8O6S (490.2322)

Asn Ile Met Asn

C19H34N6O7S (490.221)

Asn Ile Asn Met

C19H34N6O7S (490.221)

Asn Leu Met Asn

C19H34N6O7S (490.221)

Asn Leu Asn Met

C19H34N6O7S (490.221)

Asn Met Ala Arg

C18H34N8O6S (490.2322)

Asn Met Ile Asn

C19H34N6O7S (490.221)

Asn Met Leu Asn

C19H34N6O7S (490.221)

Asn Met Asn Ile

C19H34N6O7S (490.221)

Asn Met Asn Leu

C19H34N6O7S (490.221)

Asn Met Gln Val

C19H34N6O7S (490.221)

Asn Met Arg Ala

C18H34N8O6S (490.2322)

Asn Met Val Gln

C19H34N6O7S (490.221)

Asn Asn Ile Met

C19H34N6O7S (490.221)

Asn Asn Leu Met

C19H34N6O7S (490.221)

Asn Asn Met Ile

C19H34N6O7S (490.221)

Asn Asn Met Leu

C19H34N6O7S (490.221)

Asn Gln Met Val

C19H34N6O7S (490.221)

Asn Gln Val Met

C19H34N6O7S (490.221)

Asn Arg Ala Met

C18H34N8O6S (490.2322)

Asn Arg Cys Val

C18H34N8O6S (490.2322)

Asn Arg Met Ala

C18H34N8O6S (490.2322)

Asn Arg Val Cys

C18H34N8O6S (490.2322)

Asn Val Cys Arg

C18H34N8O6S (490.2322)

Asn Val Met Gln

C19H34N6O7S (490.221)

Asn Val Gln Met

C19H34N6O7S (490.221)

Asn Val Arg Cys

C18H34N8O6S (490.2322)

Pro Phe Met Pro

C24H34N4O5S (490.225)

Pro Phe Pro Met

C24H34N4O5S (490.225)

Pro His His Thr

C21H30N8O6 (490.2288)

Pro His Thr His

C21H30N8O6 (490.2288)

Pro Ile Met Met

C21H38N4O5S2 (490.2283)

Pro Leu Met Met

C21H38N4O5S2 (490.2283)

Pro Met Phe Pro

C24H34N4O5S (490.225)

Pro Met Ile Met

C21H38N4O5S2 (490.2283)

Pro Met Leu Met

C21H38N4O5S2 (490.2283)

Pro Met Met Ile

C21H38N4O5S2 (490.2283)

Pro Met Met Leu

C21H38N4O5S2 (490.2283)

Pro Met Pro Phe

C24H34N4O5S (490.225)

Pro Pro Phe Met

C24H34N4O5S (490.225)

Pro Pro Met Phe

C24H34N4O5S (490.225)

Pro Thr His His

C21H30N8O6 (490.2288)

Gln Cys Ile Gln

C19H34N6O7S (490.221)

Gln Cys Leu Gln

C19H34N6O7S (490.221)

Gln Cys Gln Ile

C19H34N6O7S (490.221)

Gln Cys Gln Leu

C19H34N6O7S (490.221)

Gln Gly Met Arg

C18H34N8O6S (490.2322)

Gln Gly Arg Met

C18H34N8O6S (490.2322)

Gln Ile Cys Gln

C19H34N6O7S (490.221)

Gln Ile Gln Cys

C19H34N6O7S (490.221)

Gln Leu Cys Gln

C19H34N6O7S (490.221)

Gln Leu Gln Cys

C19H34N6O7S (490.221)

Gln Met Gly Arg

C18H34N8O6S (490.2322)

Gln Met Asn Val

C19H34N6O7S (490.221)

Gln Met Arg Gly

C18H34N8O6S (490.2322)

Gln Met Val Asn

C19H34N6O7S (490.221)

Gln Asn Met Val

C19H34N6O7S (490.221)

Gln Asn Val Met

C19H34N6O7S (490.221)

Gln Gln Cys Ile

C19H34N6O7S (490.221)

Gln Gln Cys Leu

C19H34N6O7S (490.221)

Gln Gln Ile Cys

C19H34N6O7S (490.221)

Gln Gln Leu Cys

C19H34N6O7S (490.221)

Gln Arg Gly Met

C18H34N8O6S (490.2322)

Gln Arg Met Gly

C18H34N8O6S (490.2322)

Gln Val Met Asn

C19H34N6O7S (490.221)

Gln Val Asn Met

C19H34N6O7S (490.221)

Arg Ala Met Asn

C18H34N8O6S (490.2322)

Arg Ala Asn Met

C18H34N8O6S (490.2322)

Arg Cys Asn Val

C18H34N8O6S (490.2322)

Arg Cys Val Asn

C18H34N8O6S (490.2322)

Arg Gly Met Gln

C18H34N8O6S (490.2322)

Arg Gly Gln Met

C18H34N8O6S (490.2322)

Arg Met Ala Asn

C18H34N8O6S (490.2322)

Arg Met Gly Gln

C18H34N8O6S (490.2322)

Arg Met Asn Ala

C18H34N8O6S (490.2322)

Arg Met Gln Gly

C18H34N8O6S (490.2322)

Arg Asn Ala Met

C18H34N8O6S (490.2322)

Arg Asn Cys Val

C18H34N8O6S (490.2322)

Arg Asn Met Ala

C18H34N8O6S (490.2322)

Arg Asn Val Cys

C18H34N8O6S (490.2322)

Arg Gln Gly Met

C18H34N8O6S (490.2322)

Arg Gln Met Gly

C18H34N8O6S (490.2322)

Arg Val Cys Asn

C18H34N8O6S (490.2322)

Arg Val Asn Cys

C18H34N8O6S (490.2322)

4-Ketoretinoic acid glucuronide

C26H34O9 (490.2203)

Thr Ala His Tyr

C22H30N6O7 (490.2176)

Thr Ala Asn Trp

C22H30N6O7 (490.2176)

Thr Ala Trp Asn

C22H30N6O7 (490.2176)

Thr Ala Tyr His

C22H30N6O7 (490.2176)

Thr Glu Glu Ile

C20H34N4O10 (490.2275)

Thr Glu Glu Leu

C20H34N4O10 (490.2275)

Thr Glu Ile Glu

C20H34N4O10 (490.2275)

Thr Glu Leu Glu

C20H34N4O10 (490.2275)

Thr Phe His Ser

C22H30N6O7 (490.2176)

Thr Phe Ser His

C22H30N6O7 (490.2176)

Thr Gly Gln Trp

C22H30N6O7 (490.2176)

Thr Gly Trp Gln

C22H30N6O7 (490.2176)

Thr His Ala Tyr

C22H30N6O7 (490.2176)

Thr His Phe Ser

C22H30N6O7 (490.2176)

Thr His His Pro

C21H30N8O6 (490.2288)

Thr His Pro His

C21H30N8O6 (490.2288)

Thr His Ser Phe

C22H30N6O7 (490.2176)

Thr His Tyr Ala

C22H30N6O7 (490.2176)

Thr Ile Glu Glu

C20H34N4O10 (490.2275)

Thr Leu Glu Glu

C20H34N4O10 (490.2275)

Thr Asn Ala Trp

C22H30N6O7 (490.2176)

Thr Asn Trp Ala

C22H30N6O7 (490.2176)

Thr Pro His His

C21H30N8O6 (490.2288)

Thr Gln Gly Trp

C22H30N6O7 (490.2176)

Thr Gln Trp Gly

C22H30N6O7 (490.2176)

Thr Ser Phe His

C22H30N6O7 (490.2176)

Thr Ser His Phe

C22H30N6O7 (490.2176)

Thr Trp Ala Asn

C22H30N6O7 (490.2176)

Thr Trp Gly Gln

C22H30N6O7 (490.2176)

Thr Trp Asn Ala

C22H30N6O7 (490.2176)

Thr Trp Gln Gly

C22H30N6O7 (490.2176)

Thr Tyr Ala His

C22H30N6O7 (490.2176)

Thr Tyr His Ala

C22H30N6O7 (490.2176)

Val Cys Asn Arg

C18H34N8O6S (490.2322)

Val Cys Arg Asn

C18H34N8O6S (490.2322)

Val Met Asn Gln

C19H34N6O7S (490.221)

Val Met Gln Asn

C19H34N6O7S (490.221)

Val Asn Cys Arg

C18H34N8O6S (490.2322)

Val Asn Met Gln

C19H34N6O7S (490.221)

Val Asn Gln Met

C19H34N6O7S (490.221)

Val Asn Arg Cys

C18H34N8O6S (490.2322)

Val Gln Met Asn

C19H34N6O7S (490.221)

Val Gln Asn Met

C19H34N6O7S (490.221)

Val Arg Cys Asn

C18H34N8O6S (490.2322)

Val Arg Asn Cys

C18H34N8O6S (490.2322)

Trp Ala Asn Thr

C22H30N6O7 (490.2176)

Trp Ala Gln Ser

C22H30N6O7 (490.2176)

Trp Ala Ser Gln

C22H30N6O7 (490.2176)

Trp Ala Thr Asn

C22H30N6O7 (490.2176)

Trp Gly Gln Thr

C22H30N6O7 (490.2176)

Trp Gly Thr Gln

C22H30N6O7 (490.2176)

Trp Asn Ala Thr

C22H30N6O7 (490.2176)

Trp Asn Thr Ala

C22H30N6O7 (490.2176)

Trp Gln Ala Ser

C22H30N6O7 (490.2176)

Trp Gln Gly Thr

C22H30N6O7 (490.2176)

Trp Gln Ser Ala

C22H30N6O7 (490.2176)

Trp Gln Thr Gly

C22H30N6O7 (490.2176)

Trp Ser Ala Gln

C22H30N6O7 (490.2176)

Trp Ser Gln Ala

C22H30N6O7 (490.2176)

Trp Thr Ala Asn

C22H30N6O7 (490.2176)

Trp Thr Gly Gln

C22H30N6O7 (490.2176)

Trp Thr Asn Ala

C22H30N6O7 (490.2176)

Trp Thr Gln Gly

C22H30N6O7 (490.2176)

Tyr Ala His Thr

C22H30N6O7 (490.2176)

Tyr Ala Thr His

C22H30N6O7 (490.2176)

Tyr His Ala Thr

C22H30N6O7 (490.2176)

Tyr His Thr Ala

C22H30N6O7 (490.2176)

Tyr Thr Ala His

C22H30N6O7 (490.2176)

Tyr Thr His Ala

C22H30N6O7 (490.2176)

Austalide F

C26H34O9 (490.2203)

Crocetin glucosyl ester

C26H34O9 (490.2203)

2,6-dihydroxy-3,13-dimethoxy-5,5,7a,9,14b-pentamethyl-1,2,3,6,7,7a,10,14,14a,14b-decahydro-5H,12H-3,5a-epoxyfuro[3,4-i]oxepino[4,3-a]xanthen-12-one

C26H34O9 (490.2203)

Rhodamine 101 inner salt

C32H30N2O3 (490.2256)

butane-1,4-diol,hexanedioic acid,5-isocyanato-5-[(1-isocyanatocyclohexa-2,4-dien-1-yl)methyl]cyclohexa-1,3-diene

C25H34N2O8 (490.2315)

Ivabradine metabolite N-Demethyl Ivabradine (hydrochloride)

C26H35ClN2O5 (490.2234)

meta-Glimepiride Impurity

C24H34N4O5S (490.225)

N-((1S)-2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno(3,2-d)pyrimidin-4-yl)amino)-4,6-dihydropyrrolo(3,4-C)pyrazole-5(1H)-carboxamide

C25H30N8OS (490.2263)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor

Hexacyclinic acid

C26H34O9 (490.2203)

2-[5-(carboxymethyl)-4-[1-(furan-3-yl)-5,8a-dimethyl-3-oxo-4,6,7,8-tetrahydro-1H-isochromen-6-yl]-4-(hydroxymethyl)-2,2-dimethyloxolan-3-yl]acetic acid

C26H34O9 (490.2203)

4-hydroxy-3-(1H-indol-3-yl)-5-(3-methylbut-2-enyl)-6-[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]cyclohexa-3,5-diene-1,2-dione

C32H30N2O3 (490.2256)

PA(2:0/18:2(10E,12Z)+=O(9))

C23H39O9P (490.2332)

PA(18:2(10E,12Z)+=O(9)/2:0)

C23H39O9P (490.2332)

PA(2:0/18:2(9Z,11E)+=O(13))

C23H39O9P (490.2332)

PA(18:2(9Z,11E)+=O(13)/2:0)

C23H39O9P (490.2332)

[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C23H39O9P (490.2332)

[(2R)-2-acetyloxy-3-phosphonooxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C23H39O9P (490.2332)

[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C23H39O9P (490.2332)

[(2R)-2-acetyloxy-3-phosphonooxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C23H39O9P (490.2332)

Maoesin F

C26H34O9 (490.2203)

A natural product found in Isodon eriocalyx.

[(1S,2S,4S,5R,7E,9S,11E,14R,15R)-5,14-diacetyloxy-4,8,12-trimethyl-16-methylidene-17-oxo-3,18-dioxatricyclo[13.3.0.02,4]octadeca-7,11-dien-9-yl] acetate

C26H34O9 (490.2203)

[(8R,9R,10S)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.229)

4-(beta-D-glucopyranuronosyloxy)retinoate

C26H34O9-2 (490.2203)

[(8R,9S,10R)-9-[4-(3-methylphenyl)phenyl]-6-(2-methylphenyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.229)

[(8R,9S,10R)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.229)

(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-12-(pyridine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C27H30N4O5 (490.2216)

(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-12-methylsulfonyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C24H34N4O5S (490.225)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.225)

2-(dimethylamino)-N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.225)

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

[(8S,9R,10S)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.229)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.225)

2-(dimethylamino)-N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.225)

2-(dimethylamino)-N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.225)

2-(dimethylamino)-N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.225)

2-(dimethylamino)-N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.225)

2-(dimethylamino)-N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.225)

2-(dimethylamino)-N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.225)

2-(dimethylamino)-N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.225)

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.225)

(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-12-(pyridine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C27H30N4O5 (490.2216)

(1S,9R,10R,11R)-10-(hydroxymethyl)-11-(piperidine-1-carbonyl)-5-pyridin-4-yl-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C25H29F3N4O3 (490.2192)

(1R,9S,10S,11S)-10-(hydroxymethyl)-11-(piperidine-1-carbonyl)-5-pyridin-4-yl-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C25H29F3N4O3 (490.2192)

(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-12-methylsulfonyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C24H34N4O5S (490.225)

[(8R,9R,10R)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.229)

[(8S,9S,10R)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.229)

[(8S,9S,10S)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.229)

(1S)-N-cyclopentyl-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide

C24H34N4O5S (490.225)

1-O-all-trans-4-oxoretinoyl-beta-glucuronic acid

C26H34O9 (490.2203)

[(1S,2S,5S,8S,9R,10S,11R,12S,15R)-10,15-diacetyloxy-9-hydroxy-12-methyl-6-methylidene-7-oxo-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-12-yl]methyl acetate

C26H34O9 (490.2203)

5-(2,3-Dimethoxyphenyl)-1-[2-(dimethylamino)ethyl]-4-(5-methyl-1-phenylpyrazole-4-carbonyl)pyrrolidine-2,3-dione

C27H30N4O5 (490.2216)

(1S,9R,10R,11R)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-N-(2-pyridin-4-ylethyl)-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C25H29F3N4O3 (490.2192)

(1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-N-(2-pyridin-4-ylethyl)-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C25H29F3N4O3 (490.2192)

12-Methyl-16-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-8,15-dioxahexacyclo[14.2.1.114,17.01,13.04,12.05,9]icosa-5(9),6-dien-10-one

C26H34O9 (490.2203)

beta-D-glucosyl crocetin

C26H34O9 (490.2203)

Beta-D-glucosyl crocetin is a dicarboxylic acid monoester resulting from the formal condensation of one of the carboxylic acid groups of crocetin with the anomeric hydroxy group of beta-D-glucopyranose. It is a dicarboxylic acid monoester and a beta-D-glucoside. It is functionally related to a crocetin and a beta-D-glucose. It is a conjugate acid of a beta-D-glucosyl crocetin(1-). beta-D-glucosyl crocetin is a natural product found in Gardenia jasminoides and Crocus sativus with data available.

alpha-Crocetin glucosyl ester

C26H34O9 (490.2203)

4-Oxo-9-cis-retinoyl-beta-glucuronide

C26H34O9 (490.2203)

Estradiol acetate glucuronide

C26H34O9 (490.2203)

1-O-(4-oxoretinoyl)-beta-D-glucuronic acid

C26H34O9 (490.2203)

A ketoretinoic glucuronide obtained by the glycosylation of the carboxy group of all-trans-4-oxoretinoic acid with beta-glucuronic acid.

maoecrystal R

C26H34O9 (490.2203)

A natural product found in Isodon eriocalyx.

crassolide

C26H34O9 (490.2203)

A cembrane diterpenoid isolated from Lobophytum michaelae and has been shown to exhibit cytotoxic activity.

4-(beta-D-glucopyranuronosyloxy)retinoate(2-)

C26H34O9 (490.2203)

A retinoid glucosiduronic acid anion obtained by deprotonation of the carboxy groups of 4-(beta-D-glucopyranuronosyloxy)retinoic acid; major species at pH 7.3.

LPA 20:4;O2

C23H39O9P (490.2332)

PA 14:1/6:2;O

C23H39O9P (490.2332)

PA 20:3;O

C23H39O9P (490.2332)

ST 20:4;O3;GlcA

C26H34O9 (490.2203)

ST 20:5;O4;Hex

C26H34O9 (490.2203)

ST 23:1;O6;S

C23H38O9S (490.2236)

2,8-bis(acetyloxy)-6-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C26H34O9 (490.2203)

2,10-bis(acetyloxy)-7-hydroxy-4,14,15,15-tetramethyl-3,13-dioxotricyclo[9.3.1.1⁴,⁸]hexadeca-1(14),8-dien-5-yl acetate

C26H34O9 (490.2203)

(1r,2r,4s,7r,8s,11r,12r,13s,16r)-7-[(5r)-5-hydroxy-2-oxo-5h-furan-3-yl]-13-methoxy-1,8,12,13,15,15-hexamethyl-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecane-5,18-dione

C26H34O9 (490.2203)

(1r,2r,4r,6s,8s,9s,10s,11s,13s)-2,6-bis(acetyloxy)-8-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C26H34O9 (490.2203)

(1r,1's,2s,3r,4s,6's,9'r)-4,11'-bis(acetyloxy)-2-formyl-3-methyl-10'-methylidene-2'-oxo-3'-oxaspiro[cyclohexane-1,5'-tricyclo[7.2.1.0¹,⁶]dodecan]-3-ylmethyl acetate

C26H34O9 (490.2203)

(1r,2r,4s,15s,16s,17r,20s)-2,15-dihydroxy-13,20-dimethoxy-4,7,17,22,22-pentamethyl-5,10,21,23-tetraoxahexacyclo[18.2.1.0¹,¹⁷.0⁴,¹⁶.0⁶,¹⁴.0⁸,¹²]tricosa-6(14),7,12-trien-11-one

C26H34O9 (490.2203)

methyl (1r,4ar,5r,7s,8r,10as)-5,8-bis(acetyloxy)-7-(3-methoxy-3-oxoprop-1-en-2-yl)-1,4a-dimethyl-2-oxo-4,5,6,7,8,9,10,10a-octahydro-3h-phenanthrene-1-carboxylate

C26H34O9 (490.2203)

(1r,2r,3r,5r,6s,8s,9r,10s,11r,12r)-9,10-bis(acetyloxy)-12-hydroxy-2,5,6,12-tetramethyl-7,16-dioxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹³,¹⁷]octadeca-13(17),14-dien-3-yl acetate

C26H34O9 (490.2203)

11-o-β-d-xylopyranosylmyricanol

C26H34O9 (490.2203)

{"Ingredient_id": "HBIN000478","Ingredient_name": "11-o-\u03b2-d-xylopyranosylmyricanol","Alias": "NA","Ingredient_formula": "C26H34O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22821","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

acetylexidonin

C26H34O9 (490.2203)

{"Ingredient_id": "HBIN014473","Ingredient_name": "acetylexidonin","Alias": "NA","Ingredient_formula": "C26H34O9","Ingredient_Smile": "CC(=O)OCC1C(CCC(C12COC(=O)C34C2C(CC(C3)C(=C)C4=O)OC(=O)C)OC(=O)C)(C)C","Ingredient_weight": "490.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "393","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102004752","DrugBank_id": "NA"}

9,10-bis(acetyloxy)-12-hydroxy-2,5,6,12-tetramethyl-7,16-dioxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹³,¹⁷]octadeca-13(17),14-dien-3-yl acetate

C26H34O9 (490.2203)

(1r,2s,5r,6r,7r,8r,9r,12r)-5,8-bis(acetyloxy)-2,12-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C26H34O9 (490.2203)

(1'r,2s,2'r,7'r,8'z,12'r,13'r,14'r)-2',14'-bis(acetyloxy)-4',9',13'-trimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-3',8'-dien-12'-yl acetate

C26H34O9 (490.2203)

2,10,14,16-tetrahydroxy-6-methyl-7-(6-oxopyran-3-yl)-3-oxapentacyclo[9.7.1.0¹,¹⁴.0⁴,¹⁹.0⁶,¹⁰]nonadecan-18-yl acetate

C26H34O9 (490.2203)

(2r,3r)-4-(acetyloxy)-2-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]butyl acetate

C26H34O9 (490.2203)

(1s,2s,3r,5s,7r,8s,9s,11r,15s)-3,15-bis(acetyloxy)-9-hydroxy-12,12-dimethyl-6-methylidene-10-oxo-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-yl acetate

C26H34O9 (490.2203)

(1s,2r,3s,7s,8s,9r,12z,14s,17r)-7,9-bis(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-4,12-dien-2-yl acetate

C26H34O9 (490.2203)

2,15-dihydroxy-13,20-dimethoxy-4,7,17,22,22-pentamethyl-5,10,21,23-tetraoxahexacyclo[18.2.1.0¹,¹⁷.0⁴,¹⁶.0⁶,¹⁴.0⁸,¹²]tricosa-6(14),7,12-trien-11-one

C26H34O9 (490.2203)

(1s,2s,4s,5r,7e,9s,11e,14r,15r)-9,14-bis(acetyloxy)-4,8,12-trimethyl-16-methylidene-17-oxo-3,18-dioxatricyclo[13.3.0.0²,⁴]octadeca-7,11-dien-5-yl acetate

C26H34O9 (490.2203)

4-(acetyloxy)-2-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]butyl acetate

C26H34O9 (490.2203)

3-[(1r,2r,5r,6r,7r,10s,11s,14s)-11-(furan-3-yl)-5-(2-hydroxypropan-2-yl)-2,6,10-trimethyl-3,13-dioxo-12,15-dioxatetracyclo[8.5.0.0¹,¹⁴.0²,⁷]pentadecan-6-yl]-3-hydroxypropanoic acid

C26H34O9 (490.2203)

2,6-bis(acetyloxy)-8-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C26H34O9 (490.2203)

methyl 5,8-bis(acetyloxy)-7-(3-methoxy-3-oxoprop-1-en-2-yl)-1,4a-dimethyl-2-oxo-4,5,6,7,8,9,10,10a-octahydro-3h-phenanthrene-1-carboxylate

C26H34O9 (490.2203)

methyl (1r,4ar,5s,8r,10as)-5,8-bis(acetyloxy)-7-(3-methoxy-3-oxoprop-1-en-2-yl)-1,4a-dimethyl-2-oxo-4,5,6,7,8,9,10,10a-octahydro-3h-phenanthrene-1-carboxylate

C26H34O9 (490.2203)

(1r,2s,3r,4s,6r,7r,8r,9r,12s,13s)-9-(acetyloxy)-3-(chloromethyl)-3,12,13-trihydroxy-6-isopropyl-9,13-dimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-4-yl acetate

C24H39ClO8 (490.2333)

2,8-bis(acetyloxy)-5-[2-(furan-3-yl)-2-oxoethyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

C26H34O9 (490.2203)

2-({3,15-dihydroxy-16,17-dimethoxytricyclo[12.3.1.1²,⁶]nonadeca-1(17),2(19),3,5,14(18),15-hexaen-9-yl}oxy)oxane-3,4,5-triol

C26H34O9 (490.2203)

[(1s,2s,5r,8s,9r,10s,11r,12s,15r)-10,15-bis(acetyloxy)-9-hydroxy-12-methyl-6-methylidene-7-oxo-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-12-yl]methyl acetate

C26H34O9 (490.2203)

[10,15-bis(acetyloxy)-9-hydroxy-12-methyl-6-methylidene-7-oxo-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-12-yl]methyl acetate

C26H34O9 (490.2203)

(1s,4r,6r,7s,10s,11s,13s)-6,7-bis(acetyloxy)-8-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C26H34O9 (490.2203)

(1r,1's,2s,3r,4s,6's,9'r,11'r)-4,11'-bis(acetyloxy)-2-formyl-3-methyl-10'-methylidene-2'-oxo-3'-oxaspiro[cyclohexane-1,5'-tricyclo[7.2.1.0¹,⁶]dodecan]-3-ylmethyl acetate

C26H34O9 (490.2203)

5,8-bis(acetyloxy)-2,12-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C26H34O9 (490.2203)

methyl 3-(acetyloxy)-3-[7-(acetyloxy)-3,5a,9-trimethyl-1-oxo-8-(prop-1-en-2-yl)-6h,7h,8h,9ah,10h-pyrano[4,3-b]chromen-9-yl]propanoate

C26H34O9 (490.2203)

(3r,5s)-5-(acetyloxy)-7-(4-hydroxy-3,5-dimethoxyphenyl)-1-(4-hydroxy-3-methoxyphenyl)heptan-3-yl acetate

C26H34O9 (490.2203)

4-hydroxy-6-(1h-indol-3-yl)-5-(3-methylbut-2-en-1-yl)-3-[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]cyclohexa-3,5-diene-1,2-dione

C32H30N2O3 (490.2256)

(2s,3r,4s,5r)-2-{[(9s)-3,15-dihydroxy-16,17-dimethoxytricyclo[12.3.1.1²,⁶]nonadeca-1(17),2(19),3,5,14(18),15-hexaen-9-yl]oxy}oxane-3,4,5-triol

C26H34O9 (490.2203)

(1r,2r,4r,6s,8s,9s,10s,11s,13s)-2,8-bis(acetyloxy)-6-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C26H34O9 (490.2203)

(1s,2s,5s,6s,7r,8s,9r,12r)-5,12-bis(acetyloxy)-2,8-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C26H34O9 (490.2203)

[(1r,2r,6r,10r,11s,13s,14r,15r)-13,14-bis(acetyloxy)-1,6-dihydroxy-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-8-yl]methyl acetate

C26H34O9 (490.2203)

7',11'-bis(acetyloxy)-2-formyl-3,3-dimethyl-10'-methylidene-2'-oxo-3'-oxaspiro[cyclohexane-1,5'-tricyclo[7.2.1.0¹,⁶]dodecan]-6-yl acetate

C26H34O9 (490.2203)

2',14'-bis(acetyloxy)-4',9',13'-trimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-3',8'-dien-12'-yl acetate

C26H34O9 (490.2203)

(3r,6ar,7s,12r,12ar)-6a,12-dihydroxy-8-methoxy-3-methyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2,3,4,5,6,7,12,12a-octahydrotetraphen-1-one

C26H34O9 (490.2203)

methyl (2s)-2-hydroxy-3-[(1s,2s,7s,9r,12s,13s,16s)-9-hydroxy-2,6,6,13,16-pentamethyl-14-methylidene-5,8,11-trioxo-10-oxatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadecan-13-yl]-2-methyl-3-oxopropanoate

C26H34O9 (490.2203)

(1s,1's,2r,6s,6's,7's,9's,11'r)-7',11'-bis(acetyloxy)-2-formyl-3,3-dimethyl-10'-methylidene-2'-oxo-3'-oxaspiro[cyclohexane-1,5'-tricyclo[7.2.1.0¹,⁶]dodecan]-6-yl acetate

C26H34O9 (490.2203)

β-d-glucosyl crocetin

C26H34O9 (490.2203)

methyl (3s)-3-[(5ar,7r,8s,9s,9ar)-7-(acetyloxy)-3,5a,9-trimethyl-1-oxo-8-(prop-1-en-2-yl)-6h,7h,8h,9ah,10h-pyrano[4,3-b]chromen-9-yl]-3-(acetyloxy)propanoate

C26H34O9 (490.2203)

7,12-bis(acetyloxy)-2,8-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C26H34O9 (490.2203)

1-(1-methoxy-3-methylcarbazol-9-yl)-3,3,5-trimethyl-1h,2h,11h-pyrano[3,2-a]carbazol-2-ol

C32H30N2O3 (490.2256)

(1r,7s,8z,11r,12r,13r,14s,16s,18r)-11,12-bis(acetyloxy)-4,9,13,18-tetramethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadeca-3,8-dien-14-yl acetate

C26H34O9 (490.2203)

(1r,2r,4r,6r,7r,10s,11r,14s,16s,18r,19s)-2,10,14,16-tetrahydroxy-6-methyl-7-(6-oxopyran-3-yl)-3-oxapentacyclo[9.7.1.0¹,¹⁴.0⁴,¹⁹.0⁶,¹⁰]nonadecan-18-yl acetate

C26H34O9 (490.2203)

4,11'-bis(acetyloxy)-2-formyl-3-methyl-10'-methylidene-2'-oxo-3'-oxaspiro[cyclohexane-1,5'-tricyclo[7.2.1.0¹,⁶]dodecan]-3-ylmethyl acetate

C26H34O9 (490.2203)

6a,12-dihydroxy-8-methoxy-3-methyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2,3,4,5,6,7,12,12a-octahydrotetraphen-1-one

C26H34O9 (490.2203)

3,15-bis(acetyloxy)-9-hydroxy-12,12-dimethyl-6-methylidene-10-oxo-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-yl acetate

C26H34O9 (490.2203)

[13,14-bis(acetyloxy)-1,6-dihydroxy-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-8-yl]methyl acetate

C26H34O9 (490.2203)

(1s,2r)-1-(1-methoxy-3-methylcarbazol-9-yl)-3,3,5-trimethyl-1h,2h,11h-pyrano[3,2-a]carbazol-2-ol

C32H30N2O3 (490.2256)

(1s,1'r,2r,6s,6'r,7'r,9's)-2,7'-bis(acetyloxy)-5,5-dimethyl-10'-methylidene-2',11'-dioxo-3'-oxaspiro[cyclohexane-1,5'-tricyclo[7.2.1.0¹,⁶]dodecan]-6-ylmethyl acetate

C26H34O9 (490.2203)

(1r,2r,4ar,5s,6r,8s,8ar)-2,8-bis(acetyloxy)-5-[2-(furan-3-yl)-2-oxoethyl]-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

C26H34O9 (490.2203)

(1s,2s,3r,5s,7r,8s,9s,10r,14s)-3,14-bis(acetyloxy)-9-hydroxy-11,11-dimethyl-6-methylidene-17-oxo-16-oxapentacyclo[7.5.3.1⁵,⁸.0¹,¹⁰.0²,⁸]octadecan-7-yl acetate

C26H34O9 (490.2203)

(1s,4r,6s,8r,9s,10s,11r,16r)-8,11-bis(acetyloxy)-6-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl acetate

C26H34O9 (490.2203)

7,9-bis(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-4,12-dien-2-yl acetate

C26H34O9 (490.2203)

(1r,4r,6r,7r,10s,11r,14s,16s,18r,19s)-2,10,14,16-tetrahydroxy-6-methyl-7-(6-oxopyran-3-yl)-3-oxapentacyclo[9.7.1.0¹,¹⁴.0⁴,¹⁹.0⁶,¹⁰]nonadecan-18-yl acetate

C26H34O9 (490.2203)

(1r,2s,4s,5r,7e,9s,11e,14r,15r)-9,14-bis(acetyloxy)-4,8,12-trimethyl-16-methylidene-17-oxo-3,18-dioxatricyclo[13.3.0.0²,⁴]octadeca-7,11-dien-5-yl acetate

C26H34O9 (490.2203)

(1r,2r,4s,7r,8s,11r,12r,13s,16r)-7-(5-hydroxy-2-oxo-5h-furan-3-yl)-13-methoxy-1,8,12,13,15,15-hexamethyl-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecane-5,18-dione

C26H34O9 (490.2203)

(1s,2s,5s,6s,7s,8s,9r,12r)-7,12-bis(acetyloxy)-2,8-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C26H34O9 (490.2203)

(1s,2s,5s,6s,7r,8s,9s,12r)-5,8-bis(acetyloxy)-2,12-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C26H34O9 (490.2203)

5-(acetyloxy)-7-(4-hydroxy-3,5-dimethoxyphenyl)-1-(4-hydroxy-3-methoxyphenyl)heptan-3-yl acetate

C26H34O9 (490.2203)

3,14-bis(acetyloxy)-9-hydroxy-11,11-dimethyl-6-methylidene-17-oxo-16-oxapentacyclo[7.5.3.1⁵,⁸.0¹,¹⁰.0²,⁸]octadecan-7-yl acetate

C26H34O9 (490.2203)

(2r,4r,5r,7r,8e,10r,11s)-2,10-bis(acetyloxy)-7-hydroxy-4,14,15,15-tetramethyl-3,13-dioxotricyclo[9.3.1.1⁴,⁸]hexadeca-1(14),8-dien-5-yl acetate

C26H34O9 (490.2203)

(2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethyl-16-oxo-16-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadeca-2,4,6,8,10,12,14-heptaenoic acid

C26H34O9 (490.2203)

(1s,4r,6s,8r,9s,10s,11r,13r,16r)-8,11-bis(acetyloxy)-6-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-16-yl acetate

C26H34O9 (490.2203)

11,12-bis(acetyloxy)-4,9,13,18-tetramethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadeca-3,8-dien-14-yl acetate

C26H34O9 (490.2203)

(2s,3r,4s,5r)-2-{[(9r)-3,15-dihydroxy-16,17-dimethoxytricyclo[12.3.1.1²,⁶]nonadeca-1(17),2(19),3,5,14(18),15-hexaen-9-yl]oxy}oxane-3,4,5-triol

C26H34O9 (490.2203)

6,7-bis(acetyloxy)-8-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C26H34O9 (490.2203)

(1s,4r,6r,7s,8r,9s,10s,11s,13s)-6,7-bis(acetyloxy)-8-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C26H34O9 (490.2203)

(1r,2r,4s,6r,7s,9s,10s,11s,13s)-2,6-bis(acetyloxy)-7-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C26H34O9 (490.2203)

(8e,10e,12e,14e)-2,6,11,15-tetramethyl-16-oxo-16-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadeca-2,4,6,8,10,12,14-heptaenoic acid

C26H34O9 (490.2203)

5,9-bis(acetyloxy)-4,8,12-trimethyl-16-methylidene-17-oxo-3,18-dioxatricyclo[13.3.0.0²,⁴]octadeca-7,11-dien-14-yl acetate

C26H34O9 (490.2203)

(1r,2r,3r,5r,6s,8s,9r,10s,11r,12s)-9,10-bis(acetyloxy)-12-hydroxy-2,5,6,12-tetramethyl-7,16-dioxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹³,¹⁷]octadeca-13(17),14-dien-3-yl acetate

C26H34O9 (490.2203)

2'',8'-bis(acetyloxy)-5''-(furan-3-yl)-6'-methyl-hexahydro-2'h-dispiro[oxirane-2,1'-naphthalene-5',3''-oxolan]-8'a-ylmethyl acetate

C26H34O9 (490.2203)

(1r,2s,4s,5r,6s,7s,8r,9s)-4,8-bis(acetyloxy)-2,5-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C26H34O9 (490.2203)

(2r,2''s,4'as,5'r,5''s,6'r,8's,8'ar)-2'',8'-bis(acetyloxy)-5''-(furan-3-yl)-6'-methyl-hexahydro-2'h-dispiro[oxirane-2,1'-naphthalene-5',3''-oxolan]-8'a-ylmethyl acetate

C26H34O9 (490.2203)

(1r,2s,5s,6s,7s,8s,9s,12r)-7,12-bis(acetyloxy)-2,8-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C26H34O9 (490.2203)

methyl 3-[1-(acetyloxy)-3-methylbutyl]-6-[2-(dimethoxymethyl)-6-hydroxy-4-methylphenoxy]-2-methoxybenzoate

C26H34O9 (490.2203)